Tuomas Kiviniemi
MD, PhD, FESC
tuoski@utu.fi ORCID identifier: https://orcid.org/0000-0002-0908-3741 |
Cardiology; Clinical trials; Atrial fibrillation; Coronary artery disease; Percutaneous coronary intervention; Wearables; Anticoagulation; Bleeding; Translational research
Professor of cardiology, PI in CAREFIB and LAA-CLOSURE
Tuomas Kiviniemi, MD, PhD, FESC, is Professor of Cardiology at the University of Turku and Chief Physician at the Heart Center, Turku University Hospital. His clinical and academic work focuses on interventional cardiology, atrial fibrillation, and cardiovascular risk in patients undergoing cardiac procedures. He also serves as President of the Finnish Cardiac Society for the 2024–2026 term, contributing nationally to cardiovascular care development and professional education.
Professor Kiviniemi completed his medical and doctoral degrees at the University of Turku and later broadened his research expertise during a research fellowship at Brigham and Women’s Hospital, Harvard Medical School. His research integrates clinical trials, biomarker studies, translational science, and outcome research in percutaneous and surgical cardiac interventions. He leads the multidisciplinary CAREFIB Consortium, which encompasses several major investigator-initiated studies, including CAREBANK, CAREiCON and the LAA-CLOSURE randomized trial program investigating stroke prevention strategies in atrial fibrillation.
His scientific output includes peer-reviewed publications, book chapters, trial leadership roles, and long-term collaborations with computational medicine, imaging, and device-innovation groups.
In addition to his academic duties, Professor Kiviniemi is a frequently invited expert in the European Society of Cardiology community, contributing as an abstract reviewer, session chair, and presenter in acute coronary syndromes and interventional cardiology themes.
At the national level, he has served as a long-standing member and chair within the Finnish Cardiac Society, holding multiple leadership and editorial roles. As President of the Society 2024-2026, he advanced cardiovascular education, guidelines, and professional collaboration across Finland.
Professor Kiviniemi’s current research interests span atrial fibrillation detection technologies, outcomes after cardiac surgery, advanced imaging, and digital health solutions. His work continues to bridge clinical cardiology with engineering, data science, and translational discovery, supporting the University of Turku’s strategic strengths in cardiovascular medicine.
At the University of Turku, Professor Kiviniemi is actively involved in supervising doctoral trainees in cardiology, and he has mentored more than ten completed PhD theses. His teaching activities also include specialist training and contributions to national cardiology textbooks.
- How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ? (2018)
- Clinical Cardiology
(A1 Refereed original research article in a scientific journal) - Machine Learning Based Classification of Myocardial Infarction Conditions Using Smartphone-derived Seismo- and Gyrocardiography (2018)
- Computing in Cardiology
(A4 Refereed article in a conference publication ) - Meta-analysis of the Sources of Bleeding after Adult Cardiac Surgery (2018)
- Journal of Cardiothoracic and Vascular Anesthesia
(A2 Refereed review article in a scientific journal ) - MOBILE PHONE DETECTION OF ATRIAL FIBRILLATION: THE MODE-AF STUDY (2018)
- Journal of the American College of Cardiology
(Other publication) - Mobile Phone Detection of Atrial Fibrillation With Mechanocardiography The MODE-AF Study (Mobile Phone Detection of Atrial Fibrillation) (2018)
- Circulation
(B1 Non-refereed article in a scientific journal) - Multiclass Classifier based Cardiovascular Condition Detection Using Smartphone Mechanocardiography (2018)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - Occurrence and Classification of Cerebrovascular Events after Isolated Bioprosthetic Surgical Aortic Valve Replacement: A Competing Risk Analysis of the CAREAVR Study (2018)
- Structural Heart
(A1 Refereed original research article in a scientific journal) - Occurrence of Postpericardiotomy Syndrome: Association With Operation Type and Postoperative Mortality After Open-Heart Operations (2018)
- Journal of the American Heart Association
(A1 Refereed original research article in a scientific journal) - Optimal timing for cardioversion in patients with atrial fibrillation (2018)
- Clinical Cardiology
(A1 Refereed original research article in a scientific journal) - Performance of CHA2DS2-VASc score in stroke prediction in patients undergoing surgical aortic valve replacement with bioprosthesis (2018)
- Journal of the American College of Cardiology
(Other publication)
- CAREiCON01.09.2024 - 31.08.2027
- Internal Medicine
- LAA-CLOSURE01.09.2024 - 31.08.2028
- Internal Medicine
- MIRACLE01.10.2023 - 30.09.2027
- Internal Medicine
- CAREBANK STS01.01.2023 - 31.12.2028
- Internal Medicine
- CAREBANK01.01.2021 - 31.12.2025
- Internal Medicine
- KLL Moore4Medical01.06.2020 - 30.09.2023
- Internal Medicine



